Latest filing published 16 Aug 2022 for SQZ Biotechnologies Co, €3,872. Read the official filing
Richard Capasso is a declared insider of SQZ Biotechnologies Co, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 30 June 2022 to 15 August 2022.
Every open-market trade on record is a sale: 1 sale worth €3,872. Besides market trades, the filings include 1 share grant.
The latest filing, published on 16 August 2022, reports an open-market sale of €3,872 in SQZ Biotechnologies Co. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations